IP Library › Granted Patent US 7,202,270
Granted Patent B2
US 7,202,270 · App. 10/710,053 · Granted Apr 10, 2007

Convenient stable non-hygroscopic crystalline solid forms of racemic and chiral LA-plus salts: process for their manufacture and uses

Assignee: Sami Labs Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,202,270
App. No.
10/710,053
Granted
Apr 10, 2007
Kind
B2
Abstract

A process for the manufacture of new crystalline salts of N-[2-(dimethylamino)ethyl]-1,2-dithiolane-3-pentanamide (racemic and chiral forms) is described. Such salts are stable, crystalline and have very good solubility in water. The salts exhibit antioxidant properties. They inhibit collagenase and elastase enzymes. They have excellent anti acne activity in addition tyrosinase inhibition. They are, by themselves and in combination with other known agents, important cosmetic ingredients.

Claims (4)

1. A process for the manufacture of stable, non-hygroscopic, crystalline salts of the base (±)-N-[2-(dimethylamino)ethyl]-1,2-dithiolane-3-pentanamide((±)-N-1-[2-(dimethylamino)ethyl]-5-(1,2-dithiolan-3-yl)pentanamide, (±)-LA Plus base) which consists of reacting (±)-Lipoic acid with 1,1″-Carbonyl diimidazole followed by the addition of N,N-dimethylethylenediamine and precipitating the product with an acid component.

2. A process as claimed in claim 1 wherein the acid component is chosen from among maleic acid, fumaric acid.

3. A process for the synthesis of stable, non-hygroscopic crystalline salts of R-N-[2-(dimethylamino)ethyl]-1,2-dithiolane-3-pentanamide(R-N-1-[2-(dimethylamino)ethyl]-5-(1,2-dithiolan-3-yl)pentanamide, R-LA Plus base) which consists of reacting R-(±)-Lipoic acid with 1,1″-Carbonyl diimidazole followed by the addition of N,N-dimethylethylenediamine and precipitating the product with an acid component.

4. A process as claimed in claim 3 wherein the acid component is chosen from among maleic acid, fumaric acid.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2004
From: MAJEED, MUHAMMED; NAGABHUSHANAM, KALYANAM
To: SAMI LABS LIMITED
Reel/Frame 014794/0612 →
Continuity (2)
Provisional Application 6032029400 · Jun 20, 2003
Related Publication 20050215622A1 · Sep 29, 2005